Starling Oncology, Inc. (DFPH) Stock buybacks 2021–2024
Starling Oncology, Inc. (DFPH) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2024 · since FY2021: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $1.0M | -88.7% |
| FY2022 | $9.0M | — |
| FY2021 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH RevenueDFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating marginDFPH Operating cash flowDFPH Free cash flowDFPH Capital expendituresDFPH Return on equityDFPH Dividends paidDFPH Total assetsDFPH Total liabilitiesDFPH Shareholders’ equityDFPH overview →